{"id":"NCT00410202","sponsor":"Bristol-Myers Squibb","briefTitle":"Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus","officialTitle":"A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-resistant Chronic Hepatitis B Subjects: The DEFINE Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2011-01","completion":"2012-07","firstPosted":"2006-12-12","resultsPosted":"2012-07-04","lastUpdate":"2013-11-21"},"enrollment":629,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis B, Chronic"],"interventions":[{"type":"DRUG","name":"Entecavir","otherNames":["Baraclude","BMS-200475"]},{"type":"DRUG","name":"Tenofovir","otherNames":["Viread"]},{"type":"DRUG","name":"Adefovir","otherNames":["Hepsera"]},{"type":"DRUG","name":"Lamivudine","otherNames":["Epivir"]}],"arms":[{"label":"Entecavir","type":"ACTIVE_COMPARATOR"},{"label":"Adefovir + Lamivudine","type":"ACTIVE_COMPARATOR"},{"label":"Entecavir + Adefovir","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the effectiveness of entecavir plus adefovir combination therapy versus entecavir monotherapy or therapy with adefovir plus lamivudine","primaryOutcome":{"measure":"Percentage of Participants With Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) < 50 IU/mL (Approximately 300 Copies/mL) by Polymerase Chain Reaction (PCR) at Week 48","timeFrame":"Week 48","effectByArm":[{"arm":"ETV+ADV Combination Therapy","deltaMin":25.4,"sd":null},{"arm":"ETV Monotherapy","deltaMin":16.4,"sd":null},{"arm":"ADV+LVD Combination Therapy","deltaMin":19.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1336"},{"comp":"OG000 vs OG002","p":"0.2619"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":5},"locations":{"siteCount":67,"countries":["United States","Australia","Brazil","Canada","Greece","Hong Kong","India","Indonesia","Italy","Malaysia","Philippines","Poland","Russia","Singapore","South Korea","Taiwan","Thailand","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":[],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":137},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Headache","Dyspepsia","Hepatic steatosis"]}}